Figure 2
Figure 2. Results on target INR and clinical outcome per strategy. Estimated relative risks with 95% confidence intervals for the study period are shown. VTE: venous thromboembolism D: dabigatran R: rivaroxaban A: apixaban

Results on target INR and clinical outcome per strategy. Estimated relative risks with 95% confidence intervals for the study period are shown. VTE: venous thromboembolism D: dabigatran R: rivaroxaban A: apixaban

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal